Rapid myocardial infarction test CMY-402

myoglobinbloodchromatographic immunoassay

Product Overview
The Myoglobin Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of human myoglobin in whole blood, serum or plasma to aid in the diagnosis of myocardial infarction (MI). The test provides a visual, qualitative result suitable for point-of-care settings.

Principle
The Myoglobin Rapid Test Device is a qualitative, membrane-based immunoassay. The specimen reacts with particles coated with anti-myoglobin antibodies. This complex migrates upward on the membrane by capillary action and binds to a capture reagent pre-coated on the test line to generate a colored line. A colored line in the test region indicates a positive result; absence of the line indicates a negative result. A colored control line must appear to confirm correct sample volume and membrane function.

Kit Components

• Test devices
• Anti-myoglobin antibody-coated particles
• Capture reagent pre-coated on membrane
• Droppers
• Buffer
• Package insert

Intended Specimens and Use
Specimen types: whole blood, serum or plasma. Intended as an aid in the diagnosis of myocardial infarction (MI). For professional in vitro diagnostic use.

Interpretation
Colored test line = positive for myoglobin; no test line = negative. Colored control line must always appear to validate the test procedure.

Technical specifications

• Analyte: Human myoglobin
• Method: Rapid chromatographic immunoassay (membrane-based)
• Result type: Qualitative (visual colored line)
• Specimen: Whole blood / Serum / Plasma
• Intended use: Aid in diagnosis of myocardial infarction (MI)
• Kit components: Test devices, droppers, buffer, package insert, antibody-coated particles and capture reagent on membrane
• Internal control: Control line indicates proper sample volume and membrane wicking